Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain

被引:69
作者
Malik, Bilal [1 ]
Currais, Antonio [1 ]
Andres, Ana [1 ]
Towlson, Christopher [1 ]
Pitsi, Didier [1 ]
Nunes, Ana [1 ]
Niblock, Michael [1 ]
Cooper, Jonathan [2 ]
Hortobagyi, Tibor [3 ,4 ]
Soriano, Salvador [1 ]
机构
[1] Kings Coll London, MRC, Ctr Neurodegenerat Res, Dept Neurosci,Inst Psychiat, London SE5 8AF, England
[2] Kings Coll London, MRC, Social Genet & Dev Psychiat Ctr, Paediatr Storage Disorders Lab, London SE5 8AF, England
[3] Kings Coll Hosp London, Acad Neurosci Ctr, Dept Clin Neuropathol, London, England
[4] Univ Szeged, Dept Pathol, Szeged, Hungary
基金
英国医学研究理事会;
关键词
cell cycle; presenilin; Alzheimer's disease; beta-catenin; apoptosis;
D O I
10.4161/cc.7.5.5427
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Presenilin-1 (PS1) is a component of the beta-catenin degradation machinery, and PS1 mutations linked to familial Alzheimer's disease (FAD) represent a loss of this function, leading, in non-neuronal cells, to accumulation of cyclin D1, aberrant cell cycle activation and hyperproliferation. In post-mitotic neurons, cell cycle activation is thought to be abortive and initiate apoptosis, thus contributing to AD pathogenesis. Consequently, we tested here the hypothesis that, in the PS1 FAD brain, cyclin D1 accumulation may occur and lead to neuronal apoptosis secondary to an abortive entry into the cell cycle.
引用
收藏
页码:637 / 646
页数:10
相关论文
共 29 条
[11]  
Kang DE, 1999, J NEUROSCI, V19, P4229
[12]   Presenilin couples the paired phosphorylation of β-catenin independent of axin:: Implications for β-catenin activation in tumorigenesis [J].
Kang, DE ;
Soriano, S ;
Xia, XF ;
Eberhart, CG ;
De Strooper, B ;
Zheng, H ;
Koo, EH .
CELL, 2002, 110 (06) :751-762
[13]   Cyclin D1: polymorphism, aberrant splicing and cancer risk [J].
Knudsen, KE ;
Diehl, JA ;
Haiman, CA ;
Knudsen, ES .
ONCOGENE, 2006, 25 (11) :1620-1628
[14]   Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration [J].
Koo, EH ;
Kopan, R .
NATURE MEDICINE, 2004, 10 (07) :S26-S33
[15]  
Lippa CF, 2000, ANN NEUROL, V48, P376
[16]   The cell cycle as a therapeutic target for Alzheimer's disease [J].
Neve, Rachael L. ;
McPhie, Donna L. .
PHARMACOLOGY & THERAPEUTICS, 2006, 111 (01) :99-113
[17]   Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells [J].
Park, CH ;
Chang, JY ;
Hahm, ER ;
Park, S ;
Kim, HK ;
Yang, CH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (01) :227-234
[18]   Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration [J].
Saura, CA ;
Choi, SY ;
Beglopoulos, V ;
Malkani, S ;
Zhang, DW ;
Rao, BSS ;
Chattarji, S ;
Kelleher III, RJ ;
Kandel, ER ;
Duff, K ;
Kirkwood, A ;
Shen, J .
NEURON, 2004, 42 (01) :23-36
[19]   The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway [J].
Shtutman, M ;
Zhurinsky, J ;
Simcha, I ;
Albanese, C ;
D'Amico, M ;
Pestell, R ;
Ben-Ze'ev, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5522-5527
[20]   Presenilin 1 negatively regulates β-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of β-amyloid precursor protein and Notch processing [J].
Soriano, S ;
Kang, DE ;
Fu, MF ;
Pestell, R ;
Chevallier, N ;
Zheng, H ;
Koo, EH .
JOURNAL OF CELL BIOLOGY, 2001, 152 (04) :785-794